Sponsorisé par GlobeNewsWire
LES ULIS, France–(BUSINESS WIRE)–Regulatory News:
LFB:
| Cailliau Dedouit et Associés | PricewaterhouseCoopers Audit | |||||||||||||||
|
Montant |
HT % |
Montant |
HT % |
|||||||||||||
| Montants exprimés en milliers d’euros | ||||||||||||||||
| 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | |||||||||
| Audit | ||||||||||||||||
|
Commissariat aux comptes, certification, examen des comptes individuels et consolidés : |
||||||||||||||||
| – LFB SA | 89 | 87 | 41% | 42% | 89 | 87 | 16% | 13% | ||||||||
| – LFB Biomédicaments SA | 59 | 58 | 27% | 27% | 59 | 58 | 11% | 9% | ||||||||
| – LFB Biotechnologies SASU | 21 | 21 | 10% | 10% | 21 | 21 | 4% | 3% | ||||||||
| – LFB Hemoderivados e Biotecnologia Ltda | – | – | – | – | 32 | 30 | 6% | 4% | ||||||||
| – LFB GmbH | – | – | – | – | – | – | – | – | ||||||||
| – LFB Middle East SA | – | – | – | – | 0 | 5 | 0% | 1% | ||||||||
| – LFB Biopharmaceuticals Ltd | – | – | – | – | 0 | 0 | 0% | 0% | ||||||||
| – LFB Biomanufacturing SASU | 25 | 24 | 11% | 11% | – | – | – | – | ||||||||
| – LFB Global Plasma SASU | 3 | 3 | 2% | 1% | – | – | – | – | ||||||||
| – CellforCure SASU | 18 | 18 | 8% | 8% | – | – | – | – | ||||||||
| – rEVO Biologics Inc. | – | – | – | – | 136 | 306 | 25% | 45% | ||||||||
| – LFB USA Inc. | – | – | – | – | 93 | 93 | 17% | 14% | ||||||||
| – CAF-DCF bvba-sprl | – | – | – | – | 37 | – | 7% | – | ||||||||
| – Groupe Europlasma | – | – | – | – | 50 | 50 | 9% | 7% | ||||||||
| Sous-total certification des comptes | 215 | 209 | 99% | 100% | 517 | 649 | 96% | 96% | ||||||||
| Juridique, fiscal, social | 3 | 0 | 1% | 0% | – | – | – | – | ||||||||
| Autres | – | – | – | – | 22 | 25 | 4% | 4% | ||||||||
| Sous-total Autres diligences et prestations | 3 | 0 | 1% | 0% | 22 | 25 | 4% | 4% | ||||||||
| TOTAL | 218 | 209 | 100% | 100% | 539 | 674 | 100% | 100% | ||||||||
Contacts
LFB